Literature DB >> 11713152

Prospective randomized trial comparing oxygen administration during nasal flexible bronchoscopy : oral vs nasal delivery.

T W McCain1, D P Dunagan, N E Adair, R Chin.   

Abstract

STUDY
OBJECTIVES: To determine the optimal method of delivering supplemental oxygen during flexible bronchoscopy (FB).
DESIGN: Prospective study.
SETTING: University medical center. PATIENTS: Ninety-seven consecutive patients undergoing outpatient nasal FB during a 7-month period. INTERVENTION: During FB, delivery of oxygen was alternated weekly and administered by nasal cannula either nasally (52 patients) or orally (45 patients). Prior to the procedure, patients completed a questionnaire regarding oral or nasal breathing preferences, history of sinus disease, allergy history, and perceived degree of nasal congestion.
RESULTS: Comparison of oxygen delivery groups demonstrated no significant difference in oxygen requirements (4.1 L/min nasal vs 3.8 L/min oral, p = 0.63), overall saturation nadir (90.9% nasal vs 91.4% oral, p = 0.85), or average saturation (95.8% nasal vs 95.7% oral, p = 0.57). No correlation between subjective symptoms or sinus or allergy history was found for oxygen requirements, average saturation, or saturation nadir.
CONCLUSIONS: These data suggest that during nasal FB, no discernible difference exists between administration of oxygen using cannulas placed either nasally or orally.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713152     DOI: 10.1378/chest.120.5.1671

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Iatrogenic tension pneumothorax in children: two case reports.

Authors:  Juan Mayordomo-Colunga; Corsino Rey; Alberto Medina; Andrés Concha
Journal:  J Med Case Rep       Date:  2009-06-30

Review 2.  Oxygenation strategies during flexible bronchoscopy: a review of the literature.

Authors:  Corrado Pelaia; Andrea Bruni; Eugenio Garofalo; Serena Rovida; Eugenio Arrighi; Gianmaria Cammarota; Paolo Navalesi; Girolamo Pelaia; Federico Longhini
Journal:  Respir Res       Date:  2021-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.